Market-access contractor DKSH has signed a deal with Actelion Pharmaceuticals to help the company bolster its position in Asia. Under the agreement, DKSH will handle regulatory, distribution and logistics for Actelion in Hong Kong, Malaysia and Singapore, working to get the Swiss drugmaker's hypertension treatment Tracleer to physicians in each territory. DKSH has similar relationships with Roche ($RHHBY), Bristol-Myers Squibb ($BMY), Sanofi ($SNY), Bayer and others. More